159 related articles for article (PubMed ID: 38005931)
1. Integrase Defective Lentiviral Vector Promoter Impacts Transgene Expression in Target Cells and Magnitude of Vector-Induced Immune Responses.
Mahesh S; Li J; Travieso T; Psaradelli D; Negri D; Klotman M; Cara A; Blasi M
Viruses; 2023 Nov; 15(11):. PubMed ID: 38005931
[TBL] [Abstract][Full Text] [Related]
2. Transient Expression of Green Fluorescent Protein in Integrase-Defective Lentiviral Vector-Transduced 293T Cell Line.
Nordin F; Hamid ZA; Chan L; Farzaneh F; Hamid MK
Methods Mol Biol; 2016; 1448():159-73. PubMed ID: 27317180
[TBL] [Abstract][Full Text] [Related]
3. Integrase-defective lentiviral vectors encoding cytokines induce differentiation of human dendritic cells and stimulate multivalent immune responses in vitro and in vivo.
Daenthanasanmak A; Salguero G; Borchers S; Figueiredo C; Jacobs R; Sundarasetty BS; Schneider A; Schambach A; Eiz-Vesper B; Blasczyk R; Weissinger EM; Ganser A; Stripecke R
Vaccine; 2012 Jul; 30(34):5118-31. PubMed ID: 22691433
[TBL] [Abstract][Full Text] [Related]
4. Persistence of Integrase-Deficient Lentiviral Vectors Correlates with the Induction of STING-Independent CD8
Cousin C; Oberkampf M; Felix T; Rosenbaum P; Weil R; Fabrega S; Morante V; Negri D; Cara A; Dadaglio G; Leclerc C
Cell Rep; 2019 Jan; 26(5):1242-1257.e7. PubMed ID: 30699352
[TBL] [Abstract][Full Text] [Related]
5. Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens.
Gallinaro A; Borghi M; Bona R; Grasso F; Calzoletti L; Palladino L; Cecchetti S; Vescio MF; Macchia D; Morante V; Canitano A; Temperton N; Castrucci MR; Salvatore M; Michelini Z; Cara A; Negri D
Front Immunol; 2018; 9():171. PubMed ID: 29459873
[TBL] [Abstract][Full Text] [Related]
6. Development and Preclinical Evaluation of an Integrase Defective Lentiviral Vector Vaccine Expressing the HIVACAT T Cell Immunogen in Mice.
Gallinaro A; Borghi M; Pirillo MF; Cecchetti S; Bona R; Canitano A; Michelini Z; Di Virgilio A; Olvera A; Brander C; Negri D; Cara A
Mol Ther Methods Clin Dev; 2020 Jun; 17():418-428. PubMed ID: 32154327
[TBL] [Abstract][Full Text] [Related]
7. Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response.
Uhlig KM; Schülke S; Scheuplein VA; Malczyk AH; Reusch J; Kugelmann S; Muth A; Koch V; Hutzler S; Bodmer BS; Schambach A; Buchholz CJ; Waibler Z; Scheurer S; Mühlebach MD
J Virol; 2015 Sep; 89(17):9044-60. PubMed ID: 26085166
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk.
Mátrai J; Cantore A; Bartholomae CC; Annoni A; Wang W; Acosta-Sanchez A; Samara-Kuko E; De Waele L; Ma L; Genovese P; Damo M; Arens A; Goudy K; Nichols TC; von Kalle C; L Chuah MK; Roncarolo MG; Schmidt M; Vandendriessche T; Naldini L
Hepatology; 2011 May; 53(5):1696-707. PubMed ID: 21520180
[TBL] [Abstract][Full Text] [Related]
9. Integrase-defective lentiviral-vector-based vaccine: a new vector for induction of T cell immunity.
Negri DR; Michelini Z; Bona R; Blasi M; Filati P; Leone P; Rossi A; Franco M; Cara A
Expert Opin Biol Ther; 2011 Jun; 11(6):739-50. PubMed ID: 21434847
[TBL] [Abstract][Full Text] [Related]
10. Stability of lentiviral vector-mediated transgene expression in the brain in the presence of systemic antivector immune responses.
Abordo-Adesida E; Follenzi A; Barcia C; Sciascia S; Castro MG; Naldini L; Lowenstein PR
Hum Gene Ther; 2005 Jun; 16(6):741-51. PubMed ID: 15960605
[TBL] [Abstract][Full Text] [Related]
11. Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells.
Cui Y; Golob J; Kelleher E; Ye Z; Pardoll D; Cheng L
Blood; 2002 Jan; 99(2):399-408. PubMed ID: 11781219
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibition activates transgene expression from integration-defective lentiviral vectors in dividing and non-dividing cells.
Pelascini LP; Janssen JM; Gonçalves MA
Hum Gene Ther; 2013 Jan; 24(1):78-96. PubMed ID: 23140481
[TBL] [Abstract][Full Text] [Related]
13. One-year follow-up of transgene expression by integrase-defective lentiviral vectors and their therapeutic potential in spinocerebellar ataxia model mice.
Saida H; Matsuzaki Y; Takayama K; Iizuka A; Konno A; Yanagi S; Hirai H
Gene Ther; 2014 Sep; 21(9):820-7. PubMed ID: 24989813
[TBL] [Abstract][Full Text] [Related]
14. Simian immunodeficiency virus-Vpx for improving integrase defective lentiviral vector-based vaccines.
Negri DR; Rossi A; Blasi M; Michelini Z; Leone P; Chiantore MV; Baroncelli S; Perretta G; Cimarelli A; Klotman ME; Cara A
Retrovirology; 2012 Aug; 9():69. PubMed ID: 22913641
[TBL] [Abstract][Full Text] [Related]
15. Vaccines delivered by integration-deficient lentiviral vectors targeting dendritic cells induces strong antigen-specific immunity.
Hu B; Dai B; Wang P
Vaccine; 2010 Sep; 28(41):6675-83. PubMed ID: 20709004
[TBL] [Abstract][Full Text] [Related]
16. Transduction of human antigen-presenting cells with integrase-defective lentiviral vector enables functional expansion of primed antigen-specific CD8(+) T cells.
Negri DR; Bona R; Michelini Z; Leone P; Macchia I; Klotman ME; Salvatore M; Cara A
Hum Gene Ther; 2010 Aug; 21(8):1029-35. PubMed ID: 20210625
[TBL] [Abstract][Full Text] [Related]
17. Integrase-Defective Lentiviral Vector Is an Efficient Vaccine Platform for Cancer Immunotherapy.
Morante V; Borghi M; Farina I; Michelini Z; Grasso F; Gallinaro A; Cecchetti S; Di Virgilio A; Canitano A; Pirillo MF; Bona R; Cara A; Negri D
Viruses; 2021 Feb; 13(2):. PubMed ID: 33672349
[TBL] [Abstract][Full Text] [Related]
18. Targeted expression of two proteins in neural retina using self-inactivating, insulated lentiviral vectors carrying two internal independent promoters.
Semple-Rowland SL; Eccles KS; Humberstone EJ
Mol Vis; 2007 Oct; 13():2001-11. PubMed ID: 17982424
[TBL] [Abstract][Full Text] [Related]
19. Lentiviral vectors with CMV or MHCII promoters administered in vivo: immune reactivity versus persistence of expression.
Kimura T; Koya RC; Anselmi L; Sternini C; Wang HJ; Comin-Anduix B; Prins RM; Faure-Kumar E; Rozengurt N; Cui Y; Kasahara N; Stripecke R
Mol Ther; 2007 Jul; 15(7):1390-9. PubMed ID: 17505480
[TBL] [Abstract][Full Text] [Related]
20. Murine granulocyte-macrophage colony-stimulating factor expressed from a bicistronic simian immunodeficiency virus-based integrase-defective lentiviral vector does not enhance T-cell responses in mice.
Michelini Z; Negri D; Biava M; Baroncelli S; Spada M; Leone P; Bona R; Blasi M; Nègre D; Klotman ME; Cara A
Viral Immunol; 2014 Dec; 27(10):512-20. PubMed ID: 25343523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
